1,3,4‐Thiadiazol‐2‐amine Derivatives as Urotensin‐II Receptor (UT) Antagonists

By  

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol. 1229-5949, Iss. 10, 2015-10 ,pp. : 2549-2552

John Wiley & Sons Inc

Access to resources Recommend Favorite

(R,S)‐Diethyl {[5‐(2,4‐dichlorophenyl)‐1,3,4‐thiadiazol‐2‐ylamino](phenyl)methyl}phosphonate

By  

Best Practices in Mental Health, Vol. 63, Iss. 12, 2007-12 ,pp. : o4648-o4648

Lyceum Books

Access to resources Recommend Favorite

2‐Phenyl‐3‐{5‐[3‐(trifluoro­meth­yl)phen­yl]‐1,3,4‐thia­diazol‐2‐yl}­thia­zolidin‐4‐one

By  

Best Practices in Mental Health, Vol. 62, Iss. 9, 2006-09 ,pp. : o4072-o4074

Lyceum Books

Access to resources Recommend Favorite

The Use of H2‐Receptor Antagonists in the Nursing Home

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 4, 1992-04 ,pp. : 425-426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative QSAR and pharmacophore analysis for a series of 2,4-dihydro-3H-1,2,4-triazol-3-ones derivatives as angiotensin II AT₁ receptor antagonists

By Sharma Mukesh   Sharma Smita   Sharma Pratibha   Kumar Ashok   Bhadoriya Kamlendra  

Medicinal Chemistry Research, Vol. 23, Iss. 5, 2014-05 ,pp. : 2486-2502

Springer Publishing Company

Access to resources Recommend Favorite